Autoimmune drug gets easier shot? study tests new injection device
NCT ID NCT06293365
Summary
This study is testing if a new, single auto-injector pen delivers the same amount of the drug ianalumab into the body as two separate pre-filled syringes. It involves 155 adults with rheumatoid arthritis, lupus, or Sjögren's disease. The main goal is to see if the drug levels in the blood are comparable between the two methods, while also checking safety.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SYSTEMIC LUPUS ERYTHEMATOSUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Advanced Medical Research
La Palma, California, 90623, United States
-
Advanced Rheumatology of Houston
Spring, Texas, 77382, United States
-
Ahmed Arif Medical Research Center
Grand Blanc, Michigan, 48439, United States
-
Altoona Center for Clin Res
Duncansville, Pennsylvania, 16635, United States
-
Conquest Research
Winter Park, Florida, 32789, United States
-
Indiana Univ School of Dentistry
Indianapolis, Indiana, 46202, United States
-
Novartis Investigative Site
Quilmes, Buenos Aires, 1878, Argentina
-
Novartis Investigative Site
San Miguel de Tucumán, Tucumán Province, T4000DPK, Argentina
-
Novartis Investigative Site
Buenos Aires, 1646, Argentina
-
Novartis Investigative Site
Buenos Aires, C1055AAF, Argentina
-
Novartis Investigative Site
Hamilton, Ontario, L8N 3Z5, Canada
-
Novartis Investigative Site
Toronto, Ontario, M5T 2S8, Canada
-
Novartis Investigative Site
Rimouski, Quebec, G5L 5T1, Canada
-
Novartis Investigative Site
Trois-Rivières, Quebec, G9A 3Y2, Canada
-
Novartis Investigative Site
Brno, 638 00, Czechia
-
Novartis Investigative Site
Prague, 128 00, Czechia
-
Novartis Investigative Site
Uherské Hradiště, 686 01, Czechia
-
Novartis Investigative Site
Debrecen, Hajdu Bihar Megye, 4032, Hungary
-
Novartis Investigative Site
Budapest, 1027, Hungary
-
Novartis Investigative Site
Budapest, 1036, Hungary
-
Novartis Investigative Site
Salerno, SA, 84131, Italy
-
Novartis Investigative Site
Krakow, 30-002, Poland
-
Novartis Investigative Site
Lublin, 20-607, Poland
-
Novartis Investigative Site
Santiago Compostela, A Coruna, 15706, Spain
-
Novartis Investigative Site
A Coruña, 15006, Spain
-
Novartis Investigative Site
Madrid, 28034, Spain
-
Novel Research LLC
Bellaire, Texas, 77401, United States
-
Ochsner Health System
Baton Rouge, Louisiana, 70809, United States
-
Paramount Med Rsrch and Consult LLC
Middleburg Heights, Ohio, 44130, United States
-
Parris and Associates Rheumatology
Lawrenceville, Georgia, 30044, United States
-
Pinnacle Research Group Llc
Anniston, Alabama, 36207, United States
-
Providence Medical Foundation
Fullerton, California, 92835, United States
-
RAO Research LLC
Oklahoma City, Oklahoma, 73116, United States
-
Shelby Research LLC
Memphis, Tennessee, 38119, United States
-
Southwest Rheum Rsrch LLC
Mesquite, Texas, 75150, United States
-
Uni of Texas Health Science Center
San Antonio, Texas, 78229, United States
-
West Tennessee Research Institute
Jackson, Tennessee, 38305, United States
Conditions
Explore the condition pages connected to this study.